Christopher Brown - Zynex Vice President of Sales and Marketing

ZYXI Stock  USD 11.54  0.23  1.95%   

President

Mr. Christopher A. Brown is Vice President of Sales and Marketing of the Company. Chris Brown has spent his entire career in sales and marketing in the healthcare industry including startups, venture backed and publicly traded companies. Chris has in his career held Vice President positions with Safeop Surgical, NuvasiveImpulse Monitoring, Intelistaff Healthcare and Steris CorporationrationAMSCO. Chris holds a Bachelor Degree in Business Administration from Indiana University of Pennsylvania. since 2019.
Tenure 5 years
Address 9655 Maroon Circle, Englewood, CO, United States, 80112
Phone303 703 4906
Webhttps://www.zynex.com

Christopher Brown Latest Insider Activity

Tracking and analyzing the buying and selling activities of Christopher Brown against Zynex stock is an integral part of due diligence when investing in Zynex. Christopher Brown insider activity provides valuable insight into whether Zynex is net buyers or sellers over its current business cycle. Note, Zynex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Zynex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Zynex Management Efficiency

The company has return on total asset (ROA) of 0.0581 % which means that it generated a profit of $0.0581 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1675 %, meaning that it created $0.1675 on every $100 dollars invested by stockholders. Zynex's management efficiency ratios could be used to measure how well Zynex manages its routine affairs as well as how well it operates its assets and liabilities. The Zynex's current Return On Tangible Assets is estimated to increase to 0.09. The Zynex's current Return On Capital Employed is estimated to increase to 0.09. As of now, Zynex's Non Current Assets Total are increasing as compared to previous years. The Zynex's current Net Tangible Assets is estimated to increase to about 44.5 M, while Non Currrent Assets Other are forecasted to increase to (7.4 M).
The company currently holds 76.17 M in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. Zynex Inc has a current ratio of 3.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Zynex until it has trouble settling it off, either with new capital or with free cash flow. So, Zynex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Zynex Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Zynex to invest in growth at high rates of return. When we think about Zynex's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Paul JulianMcKesson
61
Douglas JonesPatterson Companies
N/A
Craig MercerMcKesson
N/A
Lisa CapodiciCardinal Health
N/A
Christopher LoweryOwens Minor
57
Stephen FalkCardinal Health
49
David McKinleyHenry Schein
64
Bansi NagjiMcKesson
52
Sundeep ReddyMcKesson
45
Paul GuggenheimPatterson Companies
64
Erika DavisOwens Minor
54
Richard MearsOwens Minor
54
Michael LowryOwens Minor
62
Charles ColpoOwens Minor
60
Lorelei McGlynnHenry Schein
54
Shana NealOwens Minor
55
Michael EttingerHenry Schein
63
Brian RiceCardinal Health
57
Sally CurleyCardinal Health
N/A
Les KorshPatterson Companies
54
Michael RacioppiHenry Schein
63
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people. Zynex Inc (ZYXI) is traded on NASDAQ Exchange in USA. It is located in 9655 Maroon Circle, Englewood, CO, United States, 80112 and employs 1,100 people. Zynex is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Zynex Inc Leadership Team

Elected by the shareholders, the Zynex's board of directors comprises two types of representatives: Zynex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zynex. The board's role is to monitor Zynex's management team and ensure that shareholders' interests are well served. Zynex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zynex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Sandgaard, Chairman, CEO and President Principal Financial Officer and Principal Accounting Officer
David Mogill, Vice President - Operations
Joseph Papandrea, COO
Anna Lucsok, Chief Officer
Dave Anttila, Director HR
Daniel Moorhead, Chief Officer
Steve Fox, Vice Sales
Christopher Brown, Vice President of Sales and Marketing
Donald Gregg, President Solutions
Michael Cress, Director
Joachim Sandgaard, Information Mang
Joshua Disbrow, Director
Michael Hartberger, COO
Giuseppe Papandrea, COO
Rick Luckenbill, Vice President - Finance
Barry Michaels, Director
Chelle Burkleo, VP Sales
Neil Friery, I Solutions

Zynex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zynex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zynex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zynex's short interest history, or implied volatility extrapolated from Zynex options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Zynex Stock analysis

When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Zynex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
0.27
Revenue Per Share
5.474
Quarterly Revenue Growth
0.103
Return On Assets
0.0581
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.